Build-A-Bear Workshop, Inc. (BBW) Hit a 52 Week High, Can the Run Continue? — Positive
BBW Zacks Investment Research — August 29, 2025Build-A-Bear (BBW) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Wall Street's Insights Into Key Metrics Ahead of Ciena (CIEN) Q3 Earnings — Neutral
CIEN Zacks Investment Research — August 29, 2025Get a deeper insight into the potential performance of Ciena (CIEN) for the quarter ended July 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
Boyd Gaming Corporation (BYD) Hits Fresh High: Is There Still Room to Run? — Positive
BYD Zacks Investment Research — August 29, 2025Boyd (BYD) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Deciphering Deere (DE) International Revenue Trends — Neutral
DE Zacks Investment Research — August 29, 2025Examine Deere's (DE) international revenue patterns and their implications on Wall Street's forecasts and the prospective trajectory of the stock.
Vontier Corporation (VNT) Hits Fresh High: Is There Still Room to Run? — Positive
VNT Zacks Investment Research — August 29, 2025Vontier (VNT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
What Analyst Projections for Key Metrics Reveal About Guidewire Software (GWRE) Q4 Earnings — Neutral
GWRE Zacks Investment Research — August 29, 2025Evaluate the expected performance of Guidewire Software (GWRE) for the quarter ended July 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Adaptive Biotechnologies Corporation (ADPT) Hits Fresh High: Is There Still Room to Run? — Positive
ADPT Zacks Investment Research — August 29, 2025Adaptive Biotechnologies (ADPT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Exploring Analyst Estimates for Phreesia (PHR) Q2 Earnings, Beyond Revenue and EPS — Neutral
PHR Zacks Investment Research — August 29, 2025Evaluate the expected performance of Phreesia (PHR) for the quarter ended July 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Astronics Corporation (ATRO) Hits Fresh High: Is There Still Room to Run? — Positive
ATRO Zacks Investment Research — August 29, 2025Astronics (ATRO) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Ahead of DocuSign (DOCU) Q2 Earnings: Get Ready With Wall Street Estimates for Key Metrics — Positive
DOCU Zacks Investment Research — August 29, 2025Looking beyond Wall Street's top-and-bottom-line estimate forecasts for DocuSign (DOCU), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended July 2025.
Primoris Services Corporation (PRIM) Hit a 52 Week High, Can the Run Continue? — Positive
PRIM Zacks Investment Research — August 29, 2025Primoris Services (PRIM) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
What Analyst Projections for Key Metrics Reveal About Lululemon (LULU) Q2 Earnings — Neutral
LULU Zacks Investment Research — August 29, 2025Evaluate the expected performance of Lululemon (LULU) for the quarter ended July 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Ulta Beauty Inc. (ULTA) Hit a 52 Week High, Can the Run Continue? — Positive
ULTA Zacks Investment Research — August 29, 2025Ulta (ULTA) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GSK plc – GSK — Neutral
GSK GlobeNewsWire — August 29, 2025NEW YORK, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of GSK plc (“GSK” or the “Company”) (NYSE: GSK). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Encompass Health Corporation - EHC — Neutral
EHC GlobeNewsWire — August 29, 2025NEW YORK, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Encompass Health Corporation (“Encompass” or the “Company”) (NYSE: EHC). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Exelixis, Inc. - EXEL — Neutral
EXEL GlobeNewsWire — August 29, 2025NEW YORK, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Exelixis, Inc. (“Exelixis” or the “Company”) (NASDAQ: EXEL). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Barnes & Noble Education, Inc. - BNED — Neutral
BNED GlobeNewsWire — August 29, 2025NEW YORK, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Barnes & Noble Education, Inc. (“Barnes & Noble” or the “Company”) (NYSE: BNED). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Duolingo, Inc. - DUOL — Neutral
DUOL GlobeNewsWire — August 29, 2025NEW YORK, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Duolingo, Inc. (“Duolingo” or the “Company”) (NASDAQ: DUOL). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MarineMax, Inc. – HZO — Neutral
HZO GlobeNewsWire — August 29, 2025NEW YORK, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of MarineMax, Inc. (“MarineMax” or the “Company”) (NYSE: HZO). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Telix Pharmaceuticals Limited – TLX — Neutral
TLX GlobeNewsWire — August 29, 2025NEW YORK, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Telix Pharmaceuticals Limited (“Telix” or the “Company”) (NASDAQ: TLX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
